Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
146.00    -6.80 (-4.45%)
Bid:
146.00
Ask:
153.40
Spread: 7.40 (5.068%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM Trading Statement

25 Apr 2017 07:00

ELEMENTIS PLC - AGM Trading Statement

ELEMENTIS PLC - AGM Trading Statement

PR Newswire

London, April 24

25 April 2017

AGM / Trading Statement

A positive start to the year with trading strong across the businesses.

Ahead of today’s Annual General Meeting, Elementis plc (ELM.L, the “Company" or the “Group"), the Global Specialty Chemicals Company, today issues its trading update for the three months ended 31 March 2017.Trading for the Group in the first quarter (Q1) was underpinned by stronger demand across most of our markets compared to Q1 2016. In Specialty Products, our Coatings business sector started well and we saw notably strong growth in our Personal Care and Energy business sectors. In our Chromium segment there were some indications of improved demand outside North America. In Surfactants we are benefiting from short term favourable pricing conditions which are not expected to continue indefinitely. This represents a positive start to the year and we remain on track to grow operating profit across our three segments in 2017.On 20 March 2017, we announced the sale of our non-core US colourants business and the closure of our Jersey City facility as part of our strategy to review our non-core and disadvantaged assets. On 24 March 2017, we completed our acquisition of SummitReheis and have started the integration process. It is a high quality business and we are delighted to have it in our portfolio. Commenting on the Company’s performance Paul Waterman, CEO, said: “We are off to a good start in 2017 as trading was strong across our businesses. Last November we committed to reignite growth at Elementis by focusing on four strategic priorities: pursuing the best growth opportunities, transforming our global supply chain, innovating for distinctiveness and high margins and creating a culture of high performance. We are excited to integrate SummitReheis into our Personal Care sector and look forward to completing this by the end of the year. Overall, while uncertainties exist we believe continued focus on implementing our strategy will underpin continued progress in 2017.” ENDS

Enquiries:

Elementis+ 44 (0) 207 067 2999
Paul Waterman, Chief Executive Officer Ralph Hewins, Chief Financial Officer
FTI Consulting+ 44 (0) 203 727 1000
Deborah Scott
Matthew Cole
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.